Tau monoclonal antibody generation based on humanized yeast models: Impact on tau oligomerization and diagnostics

Joëlle Rosseels, Jeff Van Den Brande, Marie Violet, Dirk Jacobs, Pierre Grognet, Juan Lopez, Isabelle Huvent, Marina Caldara, Erwin Swinnen, Anthony Papegaey, Raphaëlle Caillierez, Valerie Buée-Scherrer, Sebastiaan Engelborghs, Guy Lippens, Morvane Colin, Luc Buée, Marie Christine Galas, Eugeen Vanmechelen, Joris Winderickx

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

17 Citas (Scopus)

Resumen

Background: Oligomers of protein Tau are associated with neurodegenerative diseases. Results: New antibodies were generated and validated that recognize different degrees of oligomerization of protein Tau. Conclusion: Low order and higher order oligomers differ in C-terminal Tau phosphorylation and reflect consecutive stages in disease progression. Significance: Antibodies recognizing Tau oligomers provide insight into disease etiology and are promising diagnostic tools.

Idioma originalInglés
Páginas (desde-hasta)4059-4074
Número de páginas16
PublicaciónJournal of Biological Chemistry
Volumen290
N.º7
DOI
EstadoPublicada - 13 feb. 2015
Publicado de forma externa

Huella

Profundice en los temas de investigación de 'Tau monoclonal antibody generation based on humanized yeast models: Impact on tau oligomerization and diagnostics'. En conjunto forman una huella única.

Citar esto